Drug Approval | September 03, 2023
Zydus receives final USFDA approval for Erythromycin Tablets
Erythromycin tablets is used to prevent and treat infections in many different parts of the body
Erythromycin tablets is used to prevent and treat infections in many different parts of the body
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Sets price band at ?695 to ?735 per Equity Share
Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
The refrigerators and freezers are the latest offering in Thermo Fisher’s industry-leading portfolio of smart lab solutions
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
Zinc Sulfate Injection is indicated in adult and paediatric patients as a source of zinc for parenteral nutrition
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
Mizoram appoints Youth for Action as the Interfacing Agency for implementing the ABDM Microsite in Aizawl
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Subscribe To Our Newsletter & Stay Updated
